FDA Enforcement Active

If You Purchase Pharmaceuticals,
You Could Be Shut Down Tomorrow

DSCSA interoperability requirements have been fully in effect since November 27, 2023. The FDA is actively issuing Warning Letters and referrals for criminal prosecution. Are you prepared?

$250,000
Max fine — first violation ($1M for repeat)
6 Years
T2 record retention required
Nov 2023
Full enforcement in effect
Get Your Free Compliance Checklist

Four Ways Your Operation Is at Risk Right Now

DSCSA enforcement isn't hypothetical. These are the specific failure modes that trigger FDA action — and the consequences that follow.

No Serialization Verification

FDA can issue a Warning Letter, halt your ability to receive product, and refer your case for criminal prosecution. Each unverified package is a separate violation.

Missing T3 Documents

Transaction Information, Transaction History, and Transaction Statements (T3) must be stored for 6 years. Missing records can result in fines up to $250,000 per violation.

Uninspected Returns

Returned product must be quarantined and verified before re-entering your dispensable stock. Failure to do so exposes you to diversion liability and DSCSA enforcement.

No Recall Traceability

When FDA issues a Class I recall, you have hours — not days — to identify and quarantine affected units. Without traceability records, you cannot respond in time and may face license suspension.

Enforcement context from leading regulatory bodies

FDA

The FDA's Office of Criminal Investigations actively pursues diversion, counterfeiting, and DSCSA non-compliance as federal criminal matters — not just administrative fines.

NABP

The NABP's Verified-Accredited Wholesale Distributors (VAWD) program requires full DSCSA compliance. Loss of VAWD accreditation signals state licensing boards — and can directly trigger a license revocation review.

DEA

The DEA coordinates with FDA when supply chain irregularities suggest diversion of controlled substances. An FDA DSCSA investigation that uncovers handling gaps can escalate into a parallel DEA inquiry for Schedule II/III products.

Get Your Free DSCSA Compliance Checklist

We'll email you the full DSCSA Compliance Review and Checklist PDF immediately — no account required. Use it to audit your compliance posture before the FDA does.

We'll email you the PDF right away. No spam, no account required.

Want Zero DSCSA Risk — Permanently?

Premier Pharma includes a full DSCSA compliance platform at no additional cost for customers purchasing $500+/month. Serialization verification, T3 document storage, and recall traceability — all built in.

Open a Free Account